(Q46011013)

English

Flubendazole and ivermectin in vitro combination therapy produces a marked effect on Echinococcus granulosus protoscoleces and metacestodes.

scientific article published on 15 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

Flubendazole and ivermectin in vitro combination therapy produces a marked effect on Echinococcus granulosus protoscoleces and metacestodes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

0 references

Echinococcus granulosus

object named as

Echinococcus granulosus

1 reference

based on heuristic

inferred from title

María C. Elissondo

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

author name string

L Ceballos

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

L Alvarez

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

S Sánchez Bruni

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

C Lanusse

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

G Denegri

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

105

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

835-842

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

Could ivermectin have a synergic effect with albendazole in hydatidosis therapy?

1 reference

https://api.crossref.org/works/10.1007%2FS00436-009-1469-Y

21 January 2018

Echinococcus granulosus: first report of microcysts formation from protoscoleces of cattle origin using the in vitro vesicular culture technique

1 reference

https://api.crossref.org/works/10.1007%2FS00436-009-1469-Y

21 January 2018

Echinococcus granulosus infection: clinical presentation, medical treatment and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Avermectins and milbemycins

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of chemotherapeutic model for the in vitro screening of drugs against Echinoccus granulosus cysts: the effects of an albendazole-albendazole sulphoxide combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echinococcus granulosus: in vitro effects of ivermectin and praziquantel on hsp60 and hsp70 levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of albendazole and albendazole sulphoxide combination-therapy on Echinococcus granulosus in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effects of levamisole and ivermectin against Echinococcus granulosus protoscoleces

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of albendazole, its sulphone metabolite, and mebendazole on the viability of protoscoleces of Echinococcus granulosus in an in vitro culture system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echinococcus granulosus: praziquantel treatment against the metacestode stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depolarization of the tegument precedes morphological alterations in Echinococcus granulosus protoscoleces incubated with ivermectin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effect of praziquantel and albendazole combination therapy on the larval stage of Echinococcus granulosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between the efficacy of praziquantel treatment and the cystic differentiation in vivo of Echinococcus granulosus metacestode.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ivermectin: A Potent New Antiparasitic Agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effects of flubendazole on Echinococcus granulosus protoscoleces

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for larval echinococcosis in animals and humans: report of a workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albendazole in hydatid disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19444468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-009-1469-Y

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19444468

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46011013&oldid=2207525802"